| Literature DB >> 33623031 |
Zongliang Chang1, Weibing Qin2,3, Huili Zheng1, Kathleen Schegg1, Lu Han2,3, Xiaohua Liu2,3, Yue Wang1, Zhuqing Wang1, Hayden McSwiggin1, Hongying Peng1, Shuiqiao Yuan1, Jiabao Wu2,3, Yongxia Wang2,3, Shenghui Zhu2,3, Yanjia Jiang2,3, Hua Nie2,3, Yuan Tang2,3, Yu Zhou2,3, Michael J M Hitchcock4, Yunge Tang5,6, Wei Yan7,8,9.
Abstract
There are no non-hormonal male contraceptives currently on the market despite decades of efforts toward the development of "male pills". Here, we report that triptonide, a natural compound purified from the Chinese herb Tripterygium Wilfordii Hook F displays reversible male contraceptive effects in both mice and monkeys. Single daily oral doses of triptonide induces deformed sperm with minimal or no forward motility (close to 100% penetrance) and consequently male infertility in 3-4 and 5-6 weeks in mice and cynomolgus monkeys, respectively. Male fertility is regained in ~4-6 weeks after cessation of triptonide intake in both species. Either short- or long-term triptonide treatment causes no discernable systematic toxic side effects based on histological examination of vital organs in mice and hematological and serum biochemical analyses in monkeys. Triptonide appears to target junction plakoglobin and disrupts its interactions with SPEM1 during spermiogenesis. Our data further prove that targeting late spermiogenesis represents an effective strategy for developing non-hormonal male contraceptives.Entities:
Mesh:
Substances:
Year: 2021 PMID: 33623031 PMCID: PMC7902613 DOI: 10.1038/s41467-021-21517-5
Source DB: PubMed Journal: Nat Commun ISSN: 2041-1723 Impact factor: 14.919